- Home
- MTEM vs BDRX Comparison
MTEM vs BDRX Comparison
Compare MTEM & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEM
- BDRX
- Stock Information
- Founded
- MTEM 2001
- BDRX 2000
- Country
- MTEM United States
- BDRX United Kingdom
- Employees
- MTEM N/A
- BDRX N/A
- Industry
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- MTEM Health Care
- BDRX Health Care
- Exchange
- MTEM Nasdaq
- BDRX Nasdaq
- Market Cap
- MTEM 9.7M
- BDRX 2.8M
- IPO Year
- MTEM N/A
- BDRX N/A
- Fundamental
- Price
- MTEM $0.71
- BDRX $6.15
- Analyst Decision
- MTEM
- BDRX Strong Buy
- Analyst Count
- MTEM 0
- BDRX 1
- Target Price
- MTEM N/A
- BDRX $200.00
- AVG Volume (30 Days)
- MTEM 13.4M
- BDRX 457.8K
- Earning Date
- MTEM 11-11-2024
- BDRX 10-29-2024
- Dividend Yield
- MTEM N/A
- BDRX N/A
- EPS Growth
- MTEM N/A
- BDRX N/A
- EPS
- MTEM N/A
- BDRX N/A
- Revenue
- MTEM $25,470,000.00
- BDRX $104,895.00
- Revenue This Year
- MTEM N/A
- BDRX N/A
- Revenue Next Year
- MTEM N/A
- BDRX N/A
- P/E Ratio
- MTEM N/A
- BDRX N/A
- Revenue Growth
- MTEM N/A
- BDRX N/A
- 52 Week Low
- MTEM $0.30
- BDRX $4.71
- 52 Week High
- MTEM $6.48
- BDRX $220.25
- Technical
- Relative Strength Index (RSI)
- MTEM 38.68
- BDRX 43.80
- Support Level
- MTEM $0.31
- BDRX $5.50
- Resistance Level
- MTEM $1.34
- BDRX $10.89
- Average True Range (ATR)
- MTEM 0.14
- BDRX 1.07
- MACD
- MTEM -0.05
- BDRX 0.32
- Stochastic Oscillator
- MTEM 34.48
- BDRX 23.30
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.